Skip to content

Translation and Validation of MPCOSQ in Urdu Language

Translation and Validation of Modified Polycystic Ovary Syndrome Questionnaire in Urdu Language

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05010551
Enrollment
180
Registered
2021-08-18
Start date
2020-11-20
Completion date
2021-08-30
Last updated
2022-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PCOS- Polycystic Ovary Syndrome

Brief summary

To translate and validate modifies polycystic ovary syndrome quality of life (MPCOQ) questionnaire into Urdu. To evaluate the reliability, validity and of Urdu version of modified polycystic ovary syndrome quality of life questionnaire (MPCOQ).

Detailed description

* All statistical analyses will be conducted using the Statistical Product and Service Solution version 21 software. * Continuous variables will be shown by mean and standard deviation and the categories will be demonstrated in frequency and percentage. * In this study, factor structure of the (MPCOQ) will be analyzed using the principal component factor analysis with varimax rotation. * Intraclass Correlation Coefficient (ICC) (95% confidence interval) will be used for test-retest value and Cronbach's Alpha will be used for internal consistency analysis. * Measurement error will be determined by calculating the standard error of measurement (SEM) and the Smallest Detectable Change (SDC). Independent t-test will be used to determine the differences between groups

Interventions

None listed

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 30 Years
Healthy volunteers
No

Inclusion criteria

* • Age 18 - 30 * Married * Female patients diagnosed with PCOS, having 2 of the following Rotterdam diagnostic criteria: I. Polycystic ovaries visualized on ultrasound scan (presence of 12 follicles or more in one or both ovaries and/or increased ovarian volume \>10ml II. Clinical signs of hyperandrogenism (the hirsutism score based on the Ferriman-Gallwey score \>7 or obvious acne) III. Having an interval between menstrual periods \>35 days and/or amenorrhea as the absence of vaginal bleeding for at least 6 months, i.e. 199 days Patients who are willing to participate

Exclusion criteria

* • Non-adrenal hyperplasia, thyroid dysfunction, and hyperprolactinemia * Female undergoing Hormone Replacement Therapy * Female with malignancies * Any recent fractures, surgeries * Patient with nephrological and neurological conditions * Dementia or cognitive impairments

Design outcomes

Primary

MeasureTime frameDescription
Modified polycystic ovary syndrome quality of life questionnaire6 monthsThe tool is to measure health related quality of life of females suffering from PCOS. it contains 30 items with 6 main areas related to hirsutism , acne, weight, infertility, emotional disturbance, menstrual difficulties to define different symptoms of PCOS. then quality of life will be measured of respective patients. The total is 210 with higher score indicating a better quality of life.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026